amp domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/biosferteslab.com/httpdocs/wp-includes/functions.php on line 6260amp domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/biosferteslab.com/httpdocs/wp-includes/functions.php on line 6260rocket domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/biosferteslab.com/httpdocs/wp-includes/functions.php on line 6260
Our team has more than 100 publications in leading scientific journals worldwide.
Abstract Background and aims: Comprehensive assessment of pharmacotherapy effects on atherogenic parameters (AP) that influence the risk of cardiovascular disease …
Abstract Fecal biomarkers are becoming an important analytical tool since feces are in direct contact with the inflamed intestine and …
Abstract Introduction Empagliflozin and sacubitril/valsartan reduce cardiovascular mortality and heart failure hospitalization rates, but the effect of early initiation of …
Abstract There is growing evidence linking growth differentiation factor 15 (GDF15) to both metabolic dysfunction-associated steatotic liver disease (MASLD) and …
Abstract Background/Objectives: Assessing nutrient intake is essential for understanding body homeostasis and diet-health interactions. Traditional methods, such as dietary questionnaires …
Abstract Background: Empagliflozin and sacubitril/valsartan are established in heart failure treatment, but their effects after myocardial infarction (MI) are less …
Abstract Cardiovascular diseases keep being the leading cause of mortality in Spain. Efforts should be intensified to identify new risk …
Abstract Background and aims: We aimed to assess the associations of exposure to air pollutants and standard and advanced lipoprotein …
Abstract Background and aim: Triglycerides (TG) are independent cardiovascular risk markers, yet TG-lowering therapies have failed to reduce major adverse …
Abstract Background and aims: Atherosclerotic cardiovascular disease (ASCVD) is among the leading causes of death worldwide, and technological advances have …